Discover the key elements of President Trump's new trade deal with the EU, including significant changes to tariffs on cars, pharmaceuticals, and more. Find out how this will affect trade relations and investments!
The White House unveils a $550 billion investment agreement with Japan, promising strategic investments in key sectors. But experts raise doubts about its feasibility amidst ongoing tariff controversies.
As Trump meets EU leaders in Scotland, intense negotiations are underway to prevent a costly trade war. With key issues at stake and heavy security, will a new trade deal emerge?
Sarepta Therapeutics is under fire as another patient succumbs to acute liver failure linked to its gene therapy trial for muscular dystrophy, adding to the recent deaths of two teenage boys.
Isomorphic Labs, leveraging AI breakthroughs from DeepMind, is on the brink of human clinical trials for cancer drugs. With major pharma partnerships, the future of drug design looks promising!
As Americans gear up for Independence Day celebrations, many businesses will close their doors. Check out our guide to what's open and closed this Fourth of July, including grocery stores, pharmacies, and more!
President Trump leaves the G7 summit early to address the intensifying Israel-Iran conflict. Panic ensues in Tehran as tensions rise. Meanwhile, Purdue Pharma's $7.4 billion opioid settlement stirs debates.
All 50 states and U.S. territories have approved a monumental $7.4 billion settlement with Purdue Pharma for its role in the opioid crisis. The plan aims to hold the Sackler family accountable while providing funds for communities recovering from addiction.
A pharmacy error nearly led to tragedy for a 9-year-old boy when he was mistakenly given a potent opioid instead of his ADHD medication. His family shares their alarming experience and urges caution.
In a surprising turn, Anne Wojcicki's nonprofit, TTAM Research Institute, has acquired 23andMe for $305 million after its bankruptcy. This acquisition addresses concerns about genetic data privacy while aiming to uphold the company's mission.
